Cargando…
Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas
Medulloblastoma (MB) is the most common and aggressive paediatric brain tumour. Although the cure rate can be as high as 70%, current treatments (surgery, radio- and chemotherapy) excessively affect the patients’ quality of life. Relapses cannot be controlled by conventional or targeted treatments a...
Autores principales: | Penco-Campillo, Manon, Molina, Clément, Piris, Patricia, Soufi, Nouha, Carré, Manon, Pagnuzzi-Boncompagni, Marina, Picco, Vincent, Dufies, Maeva, Ronco, Cyril, Benhida, Rachid, Martial, Sonia, Pagès, Gilles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738107/ https://www.ncbi.nlm.nih.gov/pubmed/36497191 http://dx.doi.org/10.3390/cells11233933 |
Ejemplares similares
-
Angiogenesis and Lymphangiogenesis in Medulloblastoma Development
por: Penco-Campillo, Manon, et al.
Publicado: (2023) -
VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells
por: Penco-Campillo, Manon, et al.
Publicado: (2020) -
Author Correction: VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells
por: Penco-Campillo, Manon, et al.
Publicado: (2020) -
The ELR(+)CXCL chemokines and their receptors CXCR1/CXCR2: A signaling axis and new target for the treatment of renal cell carcinoma
por: Giuliano, Sandy, et al.
Publicado: (2014) -
Inhibiting ALK2/ALK3 Signaling to Differentiate and Chemo-Sensitize Medulloblastoma
por: Filipponi, Doria, et al.
Publicado: (2022)